Antibiotic exposure in infancy and development of BMI and body composition in childhood by Sejersen, Tobias Steen et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Antibiotic exposure in infancy and development of BMI and body composition in
childhood
Sejersen, Tobias Steen; Vinding, Rebecca Kofod; Stokholm, Jakob; Chawes, Bo;
Bønnelykke, Klaus; Krakauer, Martin; Bisgaard, Hans
Published in:
EClinicalMedicine
DOI:
10.1016/j.eclinm.2019.10.020
Publication date:
2019
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY-NC-ND
Citation for published version (APA):
Sejersen, T. S., Vinding, R. K., Stokholm, J., Chawes, B., Bønnelykke, K., Krakauer, M., & Bisgaard, H. (2019).
Antibiotic exposure in infancy and development of BMI and body composition in childhood. EClinicalMedicine,
17, [100209]. https://doi.org/10.1016/j.eclinm.2019.10.020
Download date: 06. maj. 2020
EClinicalMedicine 17 (2019) 100209
Contents lists available at ScienceDirect
EClinicalMedicine
journal homepage: https://www.journals.elsevier.com/eclinicalmedicineAntibiotic exposure in infancy and development of BMI and body
composition in childhood
Tobias Steen Sejersena,b, Rebecca Kofod Vindinga,b, Jakob Stokholma,b, Bo Chawesa,
Klaus Bønnelykkea, Martin Krakauerc, Hans Bisgaarda,*
a Copenhagen Prospective Studies on Asthma in Childhood, Health Sciences, University of Copenhagen, 2820 Gentofte, Denmark
b Department of Pediatrics, Naestved Hospital, Denmark
c Department of Clinical Physiology and Nuclear Medicine, Herlev and Gentofte Hospital, University Hospital of Copenhagen, DenmarkA R T I C L E I N F O
Article History:
Received 14 June 2019
Revised 22 October 2019
Accepted 30 October 2019
Available online 27 November 2019Abbreviations: BMI, body mass index; COPSAC2010, CO
on Asthma in Childhood2010; DXA, dual-energy X-ray a
tional Obesity Task Force; TBLH, total body less head
* Corresponding author.
E-mail address: bisgaard@copsac.com (H. Bisgaard).
https://doi.org/10.1016/j.eclinm.2019.10.020
2589-5370/© 2019 Published by Elsevier Ltd. This is an oA B S T R A C T
Background: It has been hypothesized that antibiotic usage in early life could contribute to development of
overweight in childhood. Studies have seen association between antibiotic usage and overweight in child-
hood. We aimed to investigate the relationship between antibiotic exposure in infancy and development of
body mass index (BMI) and body composition.
Methods: A prospective motherchild cohort study of 738 pregnant women and their 700 children, Copenhagen
Prospective Studies on Asthma in Childhood2010 (COPSAC2010). Information on antibiotic exposure was collected
by interviews. Height/length and weight measureswere collected at age 1, 2, 3, 4, 5 and 6 years and body compo-
sition was determined by a dual-energy X-ray absorptiometry (DXA) scan at age 3.5 and 6 years.
Findings: 306 (46%) of the 661 children were exposed to antibiotics before 1 year of age. There were no
differences in BMI z-score development at age 16 years between children exposed to antibiotics com-
pared to unexposed: z-score difference, 0.06 (95%CI: 0.17;0.06), p = 0.33, and no sex-differences
(p-interaction = 0.48). Children exposed vs. not exposed to antibiotics had comparable fat percentage
at 6 years of age: log(mean difference), 0.60% (95%CI: 0.212 to 1.41), p = 0.15.
Interpretation: Children exposed to antibiotics had similar BMI, BMI z-score and body composition between 1
and 6 years of life compared to unexposed children. Our study does not support the hypothesis that antibiotic
exposure in infancy leads to development of obesity in the first 6 years of life.
Funding: The Lundbeck Foundation, The Ministry of Health, Danish Council for Strategic Research and The
Capital Region Research Foundation.
© 2019 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license.
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The prevalence of overweight and obesity in children and adoles-
cents has been increasing worldwide [13], but seems to have
reached a plateau in the recent years in Denmark [4]. This increase in
prevalence of overweight and obesity has happened over a relatively
short period and cannot be explained by genetic predisposition and
changing dietary habits alone [5]; hence, some of the explanation
could be found in other environmental exposures [6].
Antibiotics for treatment of infections are widely used in chil-
dren during their first years of life [7]. It has been hypothesizedthat antibiotic usage in early life could be one of the environmen-
tal exposures contributing to development of overweight in child-
hood [8]. In support of this theory, it is known that antibiotics can
be used as growth promoters in livestock, however, the growth
promoting effect is poorly understood [8]. It is known that antibi-
otics can alter the gut microbiome [9,10] and recent research has
suggested that manipulation of the gut microbiota and it’s meta-
bolic pathways can affect host's adiposity and metabolism [11],
thereby linking the use of antibiotics with a potential for weight
gain.
Some studies in children have reported that antibiotics in the
early life was associated with a higher body mass index (BMI) later in
childhood, but some of these studies were based on questionnaires,
parent-reported antibiotic intake and outpatient prescriptions, with
the potential risk of bias and confounding [8,1214].
The aim of this study was to analyze the association between anti-
biotic exposure before 1 year of age and development of BMI, BMI z-
Research in context
Evidence before this study:
Antibiotics for treatment of bacterial infections are widely used
in children. Early usage of antibiotic has been suggested as a
cause of overweight and obesity in childhood, but findings are
ambiguous.
We searched PubMed for clinical trials and meta analyses on
this subject published in English, between 2014 until 2016,
using the search terms “Antibiotic usage”, “overweight/obe-
sity”, “growth” and “infant/child”. We searched the refer-
ence lists of the retrieved articles. We found no meta-
analysis on the topic.
We found that the earlier studies were predominantly based on
questionnaires, parent-reported antibiotic intake and outpatient pre-
scriptions, with the potential risk of bias and confounding. Addition-
ally, they had only few or no information on relevant confounders.
Added value of this study:
This study does not support earlier reports that use of antibiot-
ics within the first year of life leads to increased BMI or adipos-
ity later in childhood. There is no consistent evidence
supporting the role of clinical use of antibiotics in later develop-
ment of obesity.
Implications of all the available evidence:
There is not convincing evidence supporting the role of early
life antibiotics in development of obesity to change prescription
practice for this purpose. Furture studies including randomized
controlled trials should be performed to further explore this
question.
2 T.S. Sejersen et al. / EClinicalMedicine 17 (2019) 100209score and body composition from 1 to 6 years in the Danish popula-
tion-based prospective motherchild cohort Copenhagen Prospec-
tive Studies on Asthma in Childhood2010 (COPSAC2010).2. Methods
2.1. Study population
COPSAC2010 is an ongoing Danish motherchild cohort study
of 738 unselected pregnant women and their 700 children. They
are followed prospectively from pregnancy week 24 with 13 sub-
sequent scheduled clinic visits at pregnancy week 36, 1 week, 1,
3, 6, 12, 18, 24, 30, 36, 48, 60 and 72 months, together with acute
care visits [15,16]. In addition, parents kept a structured diary
with daily registrations of symptoms and medicine consumption
from birth.
Inclusion criteria were available anthropometrics data (weight
and length/height) at least at 1 and/or 6 years of age combined with
completed medical interviews (detailed information about antibiotic
usage), and a daily diary that was at least 90% fulfilled and validated
(detailed information about number of disease episodes). Children
not fulfilling these criteria were excluded.
The daily diary cards were filled from birth by parents monitoring
symptoms of illness and registering daycare absenteeism due to ill-
ness. The diary cards were reviewed with the family by the COPSAC
pediatricians at each visit to validate symptom definitions. For the
first 3 years of life the children were seen in the research clinic at age
1 week, 1 month, 3 months, 6 months and six-monthly hereafter.Furthermore, we correlated the daily dairy card information with the
prescribed medication for the children.2.2. Endpoints2.2.1. Anthropometrics
Height/length and weight were measured without clothes by
trained research assistants. We used calibrated digital weight scales.
Length was measured until the age of 2 years with Kiddimetre, Raven
Equipment Ltd [17]. Height at later ages was measured with a stadi-
ometer: Harpenden. Holtain Ltd., Crymych, Dyfed, Wales, which was
calibrated yearly. BMI was calculated by weight in kilograms divided
by height squared in meters using BMI at 1, 2, 3, 4, 5 and 6 years as
outcomes. International Obesity Task Force (IOTF) cut-offs for BMI
were used to determine risk of overweight and obesity (above grade
zero) [18].2.2.2. Dual-energy X-ray absorptiometry (DXA) scans
DXA scans were performed at 3.5 and 6 years of age as a whole-
body scan with Lunar iDXA, GE Healthcare, Fairfield, CT, USA. The
data from the DXA scans were examined and validated following rec-
ognized guidelines by experts in nuclear medicine, who were blind
to the study exposure and had no involvement in the following data
analyses [19]. DXA analyses were performed with enCoreTM soft-
ware, GE Healthcare Lunar  2011, version 14.10.022. We used fat
percentage in the compartment total body less head (TBLH) as out-
come adjusted for sex and age at measurement [20]. Pediatric mea-
surement precision was not determined on-site. The acquisition and
analysis software provides a standard deviation for total body fat per-
centage of 0.4%. The acquisition and analysis software supports pedi-
atric whole-body scans. We did not calculate Z-scores based on a
reference population as we reported the absolute measurements and
based our analyses on these values. All DXA scans were performed on
the same scanner. Previous publications on the precision of fat per-
centage estimation using the Lunar iDXA scanner found coefficients
of variation (CV) between 0.9% and 1.0% by repeat scans on the same
day [21,22]. Even though this was found in an adult population, and
to our knowledge has not been studied in children of a similar age-
group to our study population, we have no reason to believe that the
CV in our study would be significantly different, at least at the age of
6 years. Consequently, although variability could result in type 2 sta-
tistical error we do not find this likely due to the very low CV. Regard-
ing measurement error (systematic bias) this would not influence the
results due to the cross-sectional study-design.2.3. Antibiotic exposure
Detailed information on antibiotic exposure was obtained during
interviews with the participants at the scheduled clinical visits and
validated against the structured daily diary cards and The Danish
National Prescription Registry, which includes records on all drugs
collected at the pharmacy [23]. Antibiotic usage in this study was reg-
istered according to WHO’s ATC classification system and only sys-
temic administered antibiotics were used as determinants in our
analyses. Antibiotic usage was analyzed as a dichotomous variable
(yes/no) before the age of 1 year. In addition, we used antibiotic
courses as a continuous variable and in a subanalysis we stratified
the number of antibiotic courses into: 0, 1, 2, >2 to investigate any
potential cumulative effect of antibiotic exposure. We also divided
antibiotics into a group of narrow-spectrum antibiotics (penicillins
and ampicillin derivates) and a group of antibiotics which can be con-
sidered as more broad-spectrum antibiotics (macrolides, beta-lac-
tams with beta-lactamase inhibitor, cephalosporins, dicloxacillins,
aminoglycosides, trimethoprims and sulphonamides).
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Information regarding sex, race, maternal age at birth, gestational
age in weeks, mode of delivery, older children in the home, furred
animals in the home, social circumstances, passive smoking, smoking
during pregnancy, gestational diabetes, antibiotics during pregnancy,
antibiotics at birth administered to the mother, maternal asthma sta-
tus and length of exclusive breastfeeding were gathered during the
clinic visits and validated against register data whenever possible.
Length of exclusively breastfeeding was calculated in days. When the
child’s diet was supplemented or replaced by continually use (>7
days) of infant formula or other foods, we considered exclusive
breastfeeding as terminated.
Information on maternal pre-pregnancy weight was collected
from the pregnancy records and maternal BMI was calculated using
the height measured at the COPSAC clinic.
Social circumstances were defined by the z-score of the first com-
ponent of a principal component analysis (PCA) on household
income, maternal age and maternal level of education at offspring
age 2 years (explained 55% of the variance) [24].
Birth length and weight were obtained at the first clinic visit one
week after birth by personal interview and validated against the Dan-
ish Medical Birth Registry. Birth weight for gestational age z-score
was derived from ultrasound based intrauterine growth curves [25].
Number of disease episodes (cold, tonsillitis, otitis media, pneu-
monia, fever, pseudocroup and/or gastrointestinal infection) were
obtained by the daily diary recordings, requiring that each episode
had to be separated with at least one day without any symptoms.
2.5. Statistical analyses
We analyzed the association between antibiotic exposure and the
cross-sectional assessments of BMI at age 6 years and body composi-
tion at age 3.5 and 6 years using generalized linear models adjusted
for all potential confounders associated with antibiotic exposure in
the first year of life (p<0.10). Estimates are presented as differences
in BMI and fat percentage for children exposed to antibiotics com-
pared to their unexposed peers among the entire study group and
stratified for sex.
The main analysis of BMI was BMI z-score tracking over time ana-
lyzed by a similarly adjusted mixed model taking account of repeated
measures, using WHO sex specific BMI z-scores obtained at every
scheduled visit from 1 to 6 years [26]. Z-scores were used since BMI
does not have a linear development [27]. This model included only
data from 1 to 6 years, since the exposure variable was de termined
from birth to 1 year of age.
Log-transformation was performed for fat percentage values to
achieve normality of the residuals prior to analysis; log transforma-
tion was chosen by a box cox transformation.
The mothers and children in this cohort participated in a single-
center, double-blind, placebo-controlled, parallel-group study with
fish oil and high dose vitamin D supplementation in third trimester
of pregnancy [16,28]. There were no interaction between the inter-
ventions and antibiotic exposure in first year of life (data not shown).
Normality of data distribution was evaluated by histograms and a
significance level of 5% was used in all analyses. Analyses were per-
formed in SAS version 9.3 (SAS Institute Inc., Cary, NC, USA).
2.6. Ethics
The study was conducted in accordance with the guiding prin-
ciples of the Declaration of Helsinki and was approved by the Local
Ethics Committee (H-B-2008-093), and the Danish Data Protection
Agency (2015-41-3696). Both parents gave written informed con-
sent before enrolment. Data validation and quality control fol-
lowed the guidelines for good clinical practice. Data was collectedduring visits to the clinical research unit and stored in a dedicated
online database.
3. Results
3.1. Baseline characteristics
700 children were included, of which 28 were excluded due to
pre-term birth and 11 due to incomplete records on antibiotic expo-
sure, leaving 661 eligible children for the current study. 306 (46%) of
the 661 included children were exposed to treatment with systemic
antibiotics before age 1 year. 168 (25%) of the 306 children were
treated once, 65 (10%) twice and 74 (11%) children were treated three
times or more. Of the prescribed courses, 512 (88%) were beta-
lactams (ampicillin derivates, penicillins, beta-lactams with beta-lac-
tamase inhibitor or dicloxacillins), 66 (11%) of the courses were mac-
rolides, aminoglycosides or cephalosporins, and 6 (1%) of the courses
were of other types.
Table 1 shows baseline characteristics of children exposed to anti-
biotics and their unexposed peers. Older children in the home, higher
maternal pre-pregnancy BMI, antibiotic usage during pregnancy, pas-
sive smoking, and disease episodes in the first year of life were all sig-
nificantly associated with exposure to antibiotics in the first year of
life (p<0.05) and were subsequently included in the final models as
potential confounders. Children exposed to antibiotics had lower
social circumstances. This was borderline significant (p<0.07) and
was also included in as a potential confounder. Furthermore, we
included exclusive breastfeeding duration as a confounder, because
of its known influence on growth in early childhood [29]. As
expected, the number of disease episodes in the first year of life was
significantly higher among children exposed vs. unexposed to antibi-
otics: mean no. episodes (SD), 8.2 (3.9) vs. 7.2 (4.0), p-value < 0.01.
3.2. Antibiotic exposure and BMI z-score development during childhood
The development of BMI z-score from age 1 year until age 6 years
in children exposed vs. unexposed to systemic antibiotics before age
1 year is illustrated in Fig. 1, showing no differences between the
groups, except at 2 years of age where the BMI z-score estimate is
lower for the exposed vs. not exposed children, this was the same
after adjustment for confounders (data not shown). In line with this,
the repeated measurement mixed model adjusted for the confound-
ers mentioned above, showed no difference in BMI z-score from 1
year to 6 years of age between children exposed vs. not exposed to
antibiotics: 0.06 (95% CI: 0.17; 0.06), p-value = 0.33. Sex-stratified
repeated measurements models also showed no difference in BMI z-
score between children exposed to antibiotic and their unexposed
peers: girls, 0.04 (95% CI: 0.21; 0.13), p-value = 0.62, and boys,
0.08 (95% CI: 0.24; 0.08), p-value = 0.38, p-interaction = 0.48.
A post-hoc analysis of the 80 children, who were exposed to anti-
biotic before 6 months of age, revealed no difference in BMI z-score
development until to age 6 years between the exposed and unex-
posed peers (data not shown).
3.3. Number of antibiotic courses, type of antibiotics, BMI and BMI
z-score development
We subsequently examined a possible dose-response relationship
between number of antibiotic courses in the first year of life and BMI
z-score development. A repeated measurement analysis using num-
ber of antibiotic courses (0 (N = 355), 1 (N = 168), 2 (N = 65), >2
(N = 74)) as a categorical exposure variable showed no differences in
BMI z-score from 1 year to 6 year of age: 0.02 (95% CI: 0.08; 0.04),
p-value = 0.58. Furthermore, we analyzed the subpopulation of chil-
dren whom had broad spectrum antibiotics during the first year of
life. We found no difference between the children exposed to broad
Table 1
Baseline characteristics of the COPSAC2010 cohort according to antibiotic exposure in the first year of life.
Missing data Full cohort Exposed to antibiotic
before 1 year of age
Unexposed to antibiotic
before 1 year of age
P-value
Participants, N (%)  700 (100%) 306 (46%) 355 (54%) 
Females (yes), N (%)  340 (49%) 141 (46%) 182 (51%) 0.18y
Caucasian (yes), N (%)  669 (96%) 295 (96%) 339 (96%) 0.55y
Birth weight for gestational age z-score,
units, mean (SD)
 0 (1.0) 0.0 (1.0) 0.0 (1.0) 0.46z
Gestational age in weeks (without preterm),
mean (SD)
 40.1 (1.2) 40.0 (1.2) 40.1 (1.3) 0.37z
Age, mean (SD)
- 1 year data, +/- 3 months (days) 15 368.4 (15.8) 367.7 (15.0) 368.8 (16.0) 0.35z
- 6 years data, +/- 6 months (years) 54 6.0 (0.2) 6.0 (0.2) 6.0 (0.2) 0.93z
Delivery by cesarean section (yes), N (%)  151 (22%) 65 (21%) 68 (19%) 0.51y
Older children in the home (yes), N (%) 10 395 (57%) 199 (65%) 186 (53%) <0.01y
Furred animals at home (yes at 1 years visit),*
N (%)
14 338 (49%) 144 (48%) 182 (52%) 0.30y
Disease episodes in first year of life, mean
(SD)
49 7.6 (3.9) 8.2 (3.9) 7.2 (4.0) <0.01z
Exclusive breastfeeding duration, mean (SD) 8 103.1 (60.0) 102.7 (61.8) 104.5 (57.3) 0.71z
Maternal pre-pregnancy BMI, mean (SD) 84 24.5 (4.3) 25.1 (4.7) 24.1 (4.0) <0.01z
Social circumstances (PCA), mean (SD)  0 (1.0) 0.08 (1.0) 0.06 (1.0) 0.07z
Passive smoking in first year of life (yes),
N (%)
11 375 (54%) 180 (59%) 177 (50%) 0.02y
Maternal smoking during pregnancy (yes),
N (%)
 54 (8%) 22 (7%) 27 (8%) 0.84y
Gestational diabetes (yes), N (%) 3 16 (2%) 8 (2%) 8 (3%) 0.76y
Antibiotics during pregnancy (yes), N (%)  253 (36%) 126 (41%) 114 (32%) 0.02y
Maternal antibiotics at birth (yes), N (%)  223 (32%) 92 (30%) 106 (30%) 0.89y
Maternal asthma (yes), N (%) 4 187 (27%) 87 (29%) 86 (24%) 0.18y
Maternal age in years at birth, mean (SD)  32.3 (4.4) 32.1 (4.5) 32.4 (4.3) 0.45z
* Yes =minimum of 30 days (per year) with furred animal(s).
y Chi-squared test.
z Student’s T-test.
4 T.S. Sejersen et al. / EClinicalMedicine 17 (2019) 100209spectrum antibiotics in the first year of life vs. the unexposed chil-
dren: 0.07 (95% CI: 0.19; 0.05), p-value = 0.26. A cross-sectional
analysis of BMI at age 6 years showed that children exposed to antibi-
otics did not have a higher BMI compared to the unexposed group inFig. 1. Development of BMI z-score from age 1 year until age 6 years in children
exposed vs. unexposed to systemic antibiotics before age 1 year. Associations between
antibiotic exposure before 1 year of age and BMI z-score through childhood illustrated
by mean difference in BMI z-score for exposed children compared to children unex-
posed at each visit and 95% confidence intervals.the unadjusted nor adjusted analysis: adjusted mean difference,
0.07 kg/m2 (95% CI: 0.16; 0.31), p-value = 0.55. In our doseresponse
analysis we did not find any significant cumulative effect of antibiotic.
In our subanalysis we saw that children exposed to two courses had a
significantly higher BMI than the unexposed group: 0.44 kg/m2 (95%
CI: 0.01; 0.89) p-value = 0.04 in unadjusted analysis, however only
trend significant after confounder adjustment: 0.36 kg/m2 (95% CI:
0.04; 0.75) p-value = 0.07. There was no association for children
exposed to three courses or more (data not shown). We saw no differ-
ence in the BMI at 6 years of age between those children who had
broad spectrum antibiotics in the first year of life and the children who
were not exposed to antibiotics (data not shown).
3.4. Antibiotic exposure and fat percentage
The mean age for the completion of the two DXA scans was 3.5 years
(SD: 0.34) and 6.2 years (SD: 0.24), where 467 (70.1%) and 500 (75.6%)
children had usable scan data, respectively. Children exposed to antibi-
otics did not show any differences in fat percentage at either 3.5 or
6 years of age compared to children not exposed to antibiotics: 3.5 years,
difference 0.85% (95% CI: 1.84 to 3.55), p-value = 0.53, and 6 years, dif-
ference 0.60% (95% CI: 0.212 to 1.41), p-value = 0.15 (Table 2). We did
not find any differences in our dose-response analysis either (data not
shown).
4. Discussion
This study showed no association between usage of antibiotics in
the first year of life and BMI z-score development until 6 years of age.
Furthermore, there was no difference in fat percentage determined
by DXA scans at age 3.5 or 6 years of age, which argues against a role
of early life antibiotic exposure on development of childhood obesity.
The present study uses data from the prospectively monitored
clinical motherchild cohort study COPSAC2010, where participants
Table 2
Association between antibiotic usage and fat percentage from DXA scans.
A: 31/2 years of age, B: 6 years of age.
Crude Adjusted*
Exposed Geometric Mean (SD) Unexposed Geometric Mean (SD) Estimate (95% CI)** P-value
A: Fat%
28.3 (4.4) 28.4 (4.5) 0.85 (1.84 to 3.55) 0.53
On total body less head (n = 216) (n = 251)
B: Fat%
On total body less head 24.3 (1.2) 23.6 (1.2) 0.60(0.21 to 1.41) 0.15
(n = 221) (n = 279)
* Adjusted for: age, sex, disease episodes 1. year of life, passive smoking 1. year of life, maternal BMI, antibiotic during pregnancy,
other child in house, birth weight for gestational age, exclusive breastfeeding and social circumstances.
** Logged values of fat percentage.
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A significant strength of the study is the repeated anthropometric
assessments collected at a single research unit with subsequent rigor-
ous data validation, where all data was double-checked against
source data.
Another advantage is the data on fat percentage measured by DXA
scans at two age-points, which is a reliable method for quantifying
body composition in children. It was performed by experienced labo-
ratory technicians, and all scan data was validated by experts in
nuclear medicine [17,30,31].
Additionally, our study utilizes very reliable, prospectively collected
data on antibiotic usage in early life, which was validated against the
structured daily diary cards and The National Prescription Registry. By
this procedure, we possibly have minimized recall bias and excluded
antibiotics from the analysis, which were prescribed but never filled,
and which were collected at the pharmacy, but never ingested.
We had information on a broad range of potential cofounders,
which were collected at personal interviews with the families and
validated against register data. This allowed for robust adjustments
for potential confounders such as sex, child weight for gestational
age, pre-pregnancy BMI, antibiotics usage during pregnancy, social
circumstances and passive smoking [32,33]. Furthermore, we had
unique data on number of disease episodes captured in daily diary
cards with closed response categories (yes/no) filled out by the
parents and was reflective of use of antibiotics, the use of diary cards
were well validated in our earlier cohort [34]. To our knowledge this
measure for the load of infectious diseases and antibiotic exposure in
early childhood is unparalleled.
One limitation of this study is the relative low number of partici-
pants, compared to previous questionnaire based studies [8,35]. This
particularly resulted in a loss of statistical power in our doseresponse
and sex stratified analyses. Another limitation is the lacking informa-
tion on weight gain in the mothers during pregnancy and hence we
could not adjust our analyses for this potential confounder.
We chose to analyze differences in BMI estimates and not over-
weight or obesity, since we only had 31 children in risk of overweight
or obesity at age 6 years estimated by the International Obesity Task
Force (IOTF) grades [18].
Several studies have reported associations between antibiotic expo-
sure in infancy and growth measures in childhood, but most of these
were based on questionnaires or health care records with large differ-
ences in antibiotic information, age of anthropometric measurements,
and confounder adjustment, and the overall results have been ambigu-
ous [8,13,3538]. Also animals studies have demonstrated that antibi-
otics have the ability to perturb the microbiota especially in infancy
leading to long-term health consequences [39,40]. In humans; one
study reported an association between antibiotic exposure in the first 6
months of life and increased BMI at age 1038 months, but they did
not find a significant association of exposure to antibiotics at <6
months with child overweight or obesity at 7 years [8]. Another study,however, reported an association between antibiotic exposure before
6 months of age and risk of overweight at 7 years of age, but only
among children born by normal weight mothers, whereas an opposite
association was observed among children born by overweight mothers
[37]. Two other studies showed association between antibiotic expo-
sure in infancy and risk of overweight or increased BMI, but only in
boys [14,38]. Two recent studies proposed that the association with
increased BMI was mainly found after broad-spectrum antibiotic treat-
ment: The first study showed a correlation between antibiotic exposure
before 6 months of age and BMI at age 2 years, which was more pro-
nounced if the prescribed antibiotic was a macrolide [12]. The second
study showed that having 4 courses of antibiotics increased the risk
of obesity at 25 years of age, this effect was present if the prescribed
antibiotics were broad-spectrum, which accounted for more than 20%
of the courses, but there were no significant association if the pre-
scribed antibiotics were narrow-spectrum [35]. In our dose-response
analysis we do not see any cumulative effect of antibiotics. We saw
that 2 courses were borderline significant for a higher BMI, but for three
courses or more there was no association with BMI, so we interpret this
as a spurious finding.
It is known that there is a higher use of both antibiotics in general
and especially of broad-spectrum antibiotics in particular in the United
States compared to Denmark [41,42]. Murphy et al. observed that chil-
dren exposed to antibiotics within the first year of life ranged from
22% to 76% across 18 countries. Only three other countries had a lower
prevalence of exposure to antibiotics compared to our cohort from
Denmark [14]. This is reflected in the low prevalence of broad-spec-
trum antibiotic use of 11% (macrolides, aminoglycosides and cephalo-
sporins) in our cohort. In a sub-analysis comparing the children who
had broad spectrum antibiotics in the first ear of life with those with-
out antibiotics we did not see a difference in BMI between 1 and
6 years of age. Our data do not support the hypothesis that broad spec-
trum antibiotic in early life increases BMI later in life.
Recently, two studies reported negative findings in line with ours:
One study showed that children exposed to antibiotics in their first
6 months of life did not have a different growth in early childhood
compared to those not exposed [43]. Similarly, another study did not
find any impact of early antibiotic usage and changes in fat percent-
age at 3.5, 7 or 11 years of age [44].
There are several possible explanations for the observed differen-
ces. Most studies lack to our belief sufficient confounder adjustment.
We found that antibiotic use was associated with older children in
the home, maternal pre-pregnancy BMI, passive smoking, disease
episodes in the first year of life, antibiotic use during pregnancy, and
social circumstances. This could imply that antibiotic use early in life
is a proxy for socio-economic status, and thereby some of the previ-
ous observations could be explained by the relationship between dif-
ferences in socio-economics and childhood growth [45,46]. A very
important known confounder is maternal BMI that is associated with
overweight in the offspring [33] and this confounder is lacking in
6 T.S. Sejersen et al. / EClinicalMedicine 17 (2019) 100209many studies [12,14,35,44]. Our results are strengthened by the iden-
tification of several possible confounders, which have not been incor-
porated in previous reports. This strengthens the conclusions drawn
from our results.
Our study, conducted in a prospective cohort does not support
that exposure to antibiotics in early life increases BMI or fat percent-
age later in childhood. Future studies should focus on subpopulations
receiving broad-spectrum antibiotics or repetitive doses of antibiotics
in infancy and include the burden of disease episodes as a covariate.
Furthermore, the hypothesis that antibiotic exposure in infancy
causes persistent changes in the children’s gut microbiome should be
further explored.
This study does not support earlier reports that use of antibiotics
within the first year of life leads to increased BMI or adiposity later in
childhood. There is no consistent evidence supporting the role of antibi-
otics in later development of obesity. Therefore, the authors suggest
that the hypothesis of antibiotic usage in infancy as a causative factor
for later obesity should not be taken into consideration, when deciding
whether to treat with antibiotics or not in a clinical setting.Contributors’ statement page
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